Immunocore Holdings (IMCR) Interest & Investment Income (2023 - 2026)

Immunocore Holdings has disclosed Interest & Investment Income across 4 years of filings, most recently posting $3.4 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $3.4 million, down 18.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.7 million (down 27.06% YoY), and the FY2025 annual result was $16.5 million, down 35.69% from the prior year.
• Interest & Investment Income came in at $3.4 million for Q1 2026 at Immunocore Holdings, down from $3.9 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $8.2 million in Q1 2024 to a low of $3.1 million in Q1 2023.
• The 4-year median for Interest & Investment Income is $4.3 million (2023), against an average of $4.9 million.
• Across the five-year window, Interest & Investment Income jumped 163.62% in 2024 and plunged 49.36% in 2025, its largest moves.
• Immunocore Holdings' Interest & Investment Income stood at $5.4 million in 2023, then decreased by 4.91% to $5.2 million in 2024, then declined by 24.49% to $3.9 million in 2025, then dropped by 12.49% to $3.4 million in 2026.
• The last three Interest & Investment Income figures came in at $3.4 million (Q1 2026), $3.9 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.